Hepatitis C virus core antigen assay: Can we think beyond convention in resource limited settings?

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 3, 2013, Pages 369-374

  Chakravarti, Anita ^a   Chauhan, Mayank S ^a   Dogra, Gaurav ^a   Banerjee, Sayantan ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Core antigen; Diagnosis; HCVcAg; Hepatitis C

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; INDIA; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS; VIRAL LOAD;

EID: 84878422543     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.10.028     Document Type: Article

References (20)

1. Strader D.B., Wright T., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-1171. American Association for the Study of Liver Diseases, [Erratum in: Hepatology. 2004 July;40(1):269].
2. Curry M.P., Chopra S. Acute viral hepatitis. Mandell, Douglas and Bennett's principles and practice of infectious diseases 2010, 1577-1592. Churchill Livingstone, Philadelphia. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
3. Chakravarti A., Verma V. Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: a study from Northern India. Ind J Med Microbiol 2005, 23:273-274.
4. Diament D. Epidemiological aspects of hepatitis C in Brazil. Braz J Infect Dis 2007, 11(Suppl. 1):6-7.
5. Chevaliez S., Pawlotsky J.M. Use of virologic assays in the diagnosis and management of hepatitis C virus infection. Clin Liver Dis 2005, 9:371-382.
6. Bouvier-Alias M., Patel K., Dahari H., et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002, 36:211-218.
7. Simmonds P., Kurtz J., Tedder R.S. The UK blood transfusion service: over a (patent) barrel?. Lancet 2002, 359:1713-1714.
8. Diment J., Calmann M. Alternatives to nucleic acid testing in the blood transfusion service. Lancet 2002, 360:1518-1519.
9. Seme K., Poljak M., Babic D.Z., Mocilnik T., Vince A. The role of core antigen detection in management of hepatitis C: a critical review. J Clin Virol 2005, 32:92-101.
10. Miedouge M., Saune K., Kamar N., Rieu M., Rostaing L., Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010, 48:18-21.
11. Laperche S., Marrec N.L., Girault A., et al. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005, 43:3877-3883.
12. Dean L, Perry K. Seroconversion sensitivity of ORTHO antibody to HCV core antigen ELISA test system. Health Protection Agency - Centre for Infections Report NBSR06002. May, 2006 [cited 14 August 2012]. Available at. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317133424645.
13. Bianchi L., De Groote J., Desmet V.J., et al. Acute and chronic hepatitis revisited. Review by an international group. Lancet 1977, 2:914-919.
14. Mellor J., Holmes E.C., Jarvis L.M., Yap P.L., Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995, 76:2493-2507.
15. Zhang H.Q., Li S.B., Wang G.H., et al. Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China. World J Gastroenterol 2007, 13:2738-2742.
16. Chakravarti A., Verma V. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India. Transfus Med 2006, 16:433-438.
17. Netski D.M., Wang X.H., Mehta S.H., et al. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in Thai injection drug users. J Clin Microbiol 2004, 42:1631-1636.
18. Park Y., Lee J.H., Kim B.S., Kim D.Y., Han K.H., Kim H.S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010, 48:2253-2256.
19. Department of Health Statistics and Informatics. World Health Statistics 2011. Geneva: World Health Organization; 2011 [cited 14 August 2012]. Available at. http://www.who.int/whosis/whostat/EN_WHS2011_Full.pdf.
20. Department of Essential Health Technologies. Report of the Fourth General Meeting of the Global Collaboration for Blood Safety. Tunis: World Health Organization Blood Safety Programme; 2003 [cited 14 August 2012]. Available at. http://www.who.int/bloodsafety/publications/en/GCBS_Report_DEC2003.pdf.